Between Dec 19, 2024 and Jan 2, 2025, datasets can be submitted to DRUM but will not be processed until after the break. Staff will not be available to answer email during this period, and will not be able to provide DOIs until after Jan 2. If you are in need of a DOI during this period, consider Dryad or OpenICPSR. Submission responses to the UDC may also be delayed during this time.

Browsing by Subject "drug advertising"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Unbranded Vs. Branded Direct-To-Consumer Advertising (Dtca) Using Social Media Influencers: Examining The Effects Of Message Type And Disclosure
    (2020-05) Darmawan, Ida
    Social media influencer (SMI) advertising is a recent tactic conducted by pharmaceutical companies to promote a disease or a prescription drug directly to consumers. This study examined the effects of unbranded and branded direct-to-consumer (DTC) SMI advertising along with the effects of sponsorship disclosure on consumers’ attitude toward the ad and behavioral intentions. The Persuasion Knowledge Model was used as theoretical framework to understand the underlying mechanism of these effects. An online experiment with a 2 (unbranded vs. branded) x 2 (disclosure absence vs. presence) between-subject factorial design was conducted. Results showed that the unbranded message led to a higher attitude toward the ad than the branded version, and this effect was mediated by persuasion knowledge activation. Similarly, the absence of disclosure resulted in a higher attitude toward the ad than the presence of disclosure. A significant interaction effect between message type and disclosure on persuasion knowledge activation was also found. Theoretical and practical implications were discussed.